Defining the requirements for immunological control of mycobacterial infections
- 1 September 1999
- journal article
- review article
- Published by Elsevier in Trends in Microbiology
- Vol. 7 (9) , 366-372
- https://doi.org/10.1016/s0966-842x(99)01567-x
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Novel human immunodeficiencies reveal the essential role of type-1 cytokines in immunity to intracellular bacteriaImmunology Today, 1998
- An Antimicrobial Activity of Cytolytic T Cells Mediated by GranulysinScience, 1998
- The Role of TGFβ in the Pathogenesis of Human TuberculosisClinical Immunology and Immunopathology, 1998
- Analysis of the local kinetics and localization of interleukin‐1α, tumour necrosis‘qc factor‐α and transforming growth factor‐β, during the course of experimental pulmonary tuberculosisImmunology, 1997
- Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses.Journal of Clinical Investigation, 1996
- Tumor necrosis factor-α is required in the protective immune response against mycobacterium tuberculosis in miceImmunity, 1995
- Requirement for Transcription Factor IRF-1 in NO Synthase Induction in MacrophagesScience, 1994
- Multiple Defects of Immune Cell Function in Mice with Disrupted Interferon-γ GenesScience, 1993
- Macrophage deactivation by interleukin 10.The Journal of Experimental Medicine, 1991
- The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infectionCell, 1989